Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Hosp Palliat Care ; 39(3): 361-369, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34259023

RESUMO

OBJECTIVE: To determine the prevalence of prolonged grief disorder (PGD), and self-reported resilience among bereaved caregivers within a palliative care program that serves a large region of the Lower Mainland in British Columbia, Canada. Additionally, to discern effective bereavement supports utilized by caregivers following the loss of a loved one. METHODS: A descriptive study using both quantitative and qualitative methods. Sociodemographic information (n = 427) was collected from bereaved caregivers 3 months after their loss. PGD and resilience were prospectively assessed 12 months post-loss using the prolonged grief scale (PG-13, n = 212) and brief resilience scale (BRS, n = 215), respectively. A qualitative thematic analysis was conducted on responses to the open-ended question on what bereavement services or activities caregivers found helpful in coping with the loss of a loved one. RESULTS: Of the 212 individuals that completed the PG-13, 4.7% met diagnostic criteria for PGD, 27.4% were moderate risk, and 67.9% were low risk for PGD. Of the 215 caregivers that completed the BRS, 48.4% had low resilience, 51.6% had normal resilience, and 0% had high resilience. The major themes of formal supports, informal supports, and self-care activities emerged from caregiver comments regarding effective bereavement supports. CONCLUSION: The incidence of PGD in caregivers is low within the Fraser Health Palliative Care program. Bereaved caregivers mainly utilize existing social networks and activities to cope with their loss. Focusing on a community-based approach to supports may improve bereavement experiences and lower rates of prolonged grief.


Assuntos
Luto , Cuidadores , Colúmbia Britânica , Pesar , Humanos , Cuidados Paliativos
2.
Fertil Steril ; 101(6): 1718-23, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24726222

RESUMO

OBJECTIVE: To investigate X-chromosome inactivation (XCI) skewing in female newborns conceived by intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), and naturally. DESIGN: Case-control study. SETTING: Research institution. PATIENT(S): A total of 185 female newborns, including 60 conceived by intracytoplasmic sperm injection (ICSI), 73 by in vitro fertilization (IVF), and 52 naturally conceived (NC). INTERVENTION(S): DNA was extracted from umbilical cord blood after birth. MAIN OUTCOME MEASURE(S): XCI skewing values determined by assaying allelic ratio of methylated alleles at the androgen receptor (AR), fragile X mental retardation 1 (FMR1), and DXS6673E loci. RESULT(S): In the comparison of the ICSI, IVF, and NC populations, the frequency of skewing ≥ 75% (7.0% vs. 5.7% vs. 2.0%, respectively) or ≥ 90% (0 vs. 1.4% vs. 2.0%, respectively) was not statistically significantly different. The mean level of skewing between the ICSI, IVF, and NC groups also did not differ (63.7% vs. 61.8% vs. 60.7%, respectively). Skewing variability was observed in the placentas of the two extremely skewed cases. The parental origin of the preferentially inactivated X chromosome in the extremely skewed IVF and NC cases were maternal and paternal, respectively. CONCLUSION(S): The assisted reproductive technologies of ICSI and IVF do not appear to affect XCI skewing. Skewing variability within the placentas analyzed supports the theory that weaker selective pressures occur in the placenta that could result in skewed inactivation. Our study is the largest to date to investigate this epigenetic phenomenon in infants conceived by ICSI and IVF alongside age-matched NC controls.


Assuntos
Fertilização in vitro/efeitos adversos , Inativação do Cromossomo X , Canadá , Estudos de Casos e Controles , Metilação de DNA , Epigênese Genética , Feminino , Sangue Fetal/química , Proteína do X Frágil da Deficiência Intelectual/genética , Humanos , Recém-Nascido , Idade Materna , Proteínas Nucleares/genética , Gravidez , Receptores Androgênicos/genética , Fatores de Risco , Injeções de Esperma Intracitoplásmicas/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...